P3.18.02 Sex-Based Differences in Immunotherapy Response via Blood Biomarkers in NSCLC: Interim Results From the ALICE Study
Back to course
Asset Subtitle
Melis Aykac-Bicer
Meta Tag
Speaker Melis Aykac-Bicer
Topic Clinical Trials in Progress
Powered By